CART-I
Despite a dry investment climate, it was able to secure what could be the biggest funding raise by a health tech company in South Korea this year.
The company targets to receive a similar clearance from the US FDA by yearend.
Also, South Korean startup Lunit obtains two new US FDA approvals for its AI diagnostic tools.